In the present in vitro study, Western blotting analysis indicated that D-allose stimulated TXNIP expression, consistent with previous studies on other cancer types [5,6,7], and the FACS analysis revealed the up-regulation of intracellular ROS levels after treatment with D-allose. The gene discussed is TXNIP; the disease is cancer.